Agenus Inc.
This person does not yet have a bio.Content by Agenus Inc.
| 3 min read
Dr. Garo Armen, Chairman and CEO of Agenus Inc., examines adjuvants and their potential in light of the growing interest and favorable
market scene for cancer vaccines.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
Preparing data for AI/ML predictive modeling
Mastering data preparation is key to harnessing the full potential of advanced computational tools.
A Technology Guide for CRISPR Screening
Emerging CRISPR screening methods are shaping what’s possible in drug development and precision medicine.
